Infliximab in Steroid-dependent Ulcerative Colitis
Open Access
- 1 April 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (5) , 1065-1072
Abstract
Background. Up to 20% of patients with ulcerative colitis (UC) become steroid-dependent during their course. Thiopurines are recommended in steroid-dependent UCKeywords
This publication has 25 references indexed in Scilit:
- Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitisJournal of Crohn's and Colitis, 2009
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosisJournal of Crohn's and Colitis, 2008
- European evidence-based Consensus on the management of ulcerative colitis: Current managementJournal of Crohn's and Colitis, 2008
- Review article: the management of steroid dependency in ulcerative colitisAlimentary Pharmacology & Therapeutics, 2007
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Anti-Tumor Necrosis Factor Therapy for Ulcerative ColitisGastroenterology, 2005
- Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitisGut, 2005
- Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm CountyGut, 2004
- Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitisRevista Española de Enfermedades Digestivas, 2004
- Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitisAmerican Journal of Gastroenterology, 2002